This retrospective study aimed to evaluate the benefit of switching from calcineurin inhibitors (CnI) to sirolimus in posttransplant Kaposi's sarcoma (KS). Fourteen patients monitored in five French departments who had developed posttransplant KS were switched from CnI to sirolimus either abruptly (n=9) or progressively (n=5) with trough levels 5-12 ng/mL. Two patients had a complete remission, eight a partial response, and five no significant improvement of KS. The mean time to response was 3.9 months. After a mean follow-up of 16 months, 3 partial responders, with previous severe and refractory KS, suffered again from KS progression despite the lack of concomitant infectious or neoplastic event. These relapses occurred 5-9 months after switching. The tolerance of sirolimus has been excellent except for in one patient who developed severe interstitial pneumonitis. Sirolimus is usually useful in the management of posttransplant KS. It may be, however, ineffective or transiently effective in some patients with severe KS. Prospective studies with pharmacodynamic evaluation are important in order to better assess the duration of responses and the mechanisms of primary and acquired drug resistance.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1600-6143.2006.01412.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical management of human herpesvirus-8-related illnesses in solid organ transplant recipients.
J Infect
January 2025
Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK; Centre for Immunology and Vaccinology, Department of Infectious Diseases, Imperial College, London, UK. Electronic address:
In solid organ transplant recipients (SOTRs), the oncogenic virus human herpesvirus-8 (HHV-8) also named Kaposi sarcoma herpesvirus (KSHV) causes four clinical diseases: Kaposi Sarcoma, Primary Effusion Lymphoma, Multicentric Castleman Disease (MCD), and KSHV inflammatory cytokine syndrome (KICS). This review outlines these clinical scenarios and discusses their management. Although HHV8-related disease in SOTR was first described more than three decades ago, there is a lack of data on treatment so much of the guidance is based on evidence in other immunodeficient patients, particularly people living with HIV.
View Article and Find Full Text PDFUbiquitin-Mediated Effects on Oncogenesis during EBV and KSHV Infection.
Viruses
September 2024
Department of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA.
Article Synopsis
- The Epstein-Barr Virus (EBV) and Kaposi Sarcoma-associated Herpesvirus (KSHV) are both cancer-causing viruses that utilize host cellular mechanisms to promote their replication and the development of cancer.
- EBV infects around 90% of people globally and is linked to several cancers like Burkitt lymphoma and nasopharyngeal carcinoma, manipulating ubiquitin pathways to enhance cell proliferation and evade apoptosis.
- KSHV, responsible for Kaposi's Sarcoma, also employs similar ubiquitin-mediated strategies to degrade tumor suppressors and evade immune responses, making both viruses significant in understanding viral oncogenesis and potential cancer therapies.
Cytokine Dynamics and Herpesvirus Interactions in Pediatric Liver and Kidney Transplant Recipients: The Distinct Behavior of HCMV, HHV6, HHV7 and EBV.
Viruses
July 2024
Clinical Pathology Department, Children's Hospital of Mexico Federico Gómez, Mexico City 06720, Mexico.
Article Synopsis
- * In a study measuring cytokine levels in 158 pediatric kidney and liver transplant patients, higher levels of IL-4, IL-8, and IL-10 were found to be associated with graft rejection, especially in cases with certain herpesviruses present.
- * The research stresses the need for closer monitoring of not just EBV and HCMV, but also HHV6 and HHV7 to improve risk assessment and treatment strategies for pediatric transplant patients.
Emerging shadows: HHV-8-associated encephalitis unveiled in a solid organ transplant recipient.
Transpl Infect Dis
August 2024
Section of Infectious Diseases, UT Health McGovern Medical School, Houston, Texas, USA.
Article Synopsis
- Human herpesviruses (HHVs) can cause serious brain infections like meningitis and encephalitis.
- HHV-8, usually not linked to brain issues, was found to cause encephalitis in a patient who had just received an organ transplant and had a related disease called Kaposi's Sarcoma.
- The patient was treated with special antiviral medicine, showing that it's important for doctors to be aware of HHV-8 risks in transplant patients.
High malignancy rate in the absence of viral prophylaxis after kidney transplantation in Sudan.
J Nephrol
July 2024
Histopathology Department, National University, Khartoum, Sudan.
Background: Kidney transplantation in Sudan is funded by the government. Cytomegalovirus prophylaxis is provided for patients who receive biological induction or have recipient-negative donor-positive cytomegalovirus serology. Doctor Selma Center for Kidney Diseases joined the national kidney transplant program in May 2019.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!